Sage Therapeutics, Inc. (SAGE)
USD 6.45
(-5.98%)
USD 6.45
(-5.98%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 664.14 Million USD | 13.88% |
| 2022 | 553.86 Million USD | 18.69% |
| 2021 | 466.66 Million USD | -4.7% |
| 2020 | 489.66 Million USD | -31.48% |
| 2019 | 714.59 Million USD | 47.79% |
| 2018 | 483.51 Million USD | 77.01% |
| 2017 | 273.15 Million USD | 70.55% |
| 2016 | 160.16 Million USD | 69.22% |
| 2015 | 94.65 Million USD | 179.95% |
| 2014 | 33.81 Million USD | 84.97% |
| 2013 | 18.27 Million USD | 89.79% |
| 2012 | 9.63 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 107.79 Million USD | -9.07% |
| 2024 Q1 | 123.71 Million USD | 3.58% |
| 2024 Q2 | 118.54 Million USD | -4.17% |
| 2023 FY | 630.75 Million USD | 13.88% |
| 2023 Q4 | 119.43 Million USD | -33.67% |
| 2023 Q2 | 172.72 Million USD | 8.95% |
| 2023 Q3 | 180.06 Million USD | 4.25% |
| 2023 Q1 | 158.53 Million USD | 1.22% |
| 2022 Q3 | 143.03 Million USD | 10.27% |
| 2022 Q2 | 129.7 Million USD | 4.19% |
| 2022 FY | 553.86 Million USD | 18.69% |
| 2022 Q1 | 124.49 Million USD | -2.0% |
| 2022 Q4 | 156.62 Million USD | 9.5% |
| 2021 Q2 | 109.51 Million USD | 11.86% |
| 2021 FY | 466.66 Million USD | -4.7% |
| 2021 Q1 | 97.9 Million USD | -27.59% |
| 2021 Q4 | 127.04 Million USD | -3.9% |
| 2021 Q3 | 132.2 Million USD | 20.72% |
| 2020 Q4 | 135.2 Million USD | 23.84% |
| 2020 Q2 | 111.54 Million USD | -16.6% |
| 2020 Q1 | 133.74 Million USD | -24.17% |
| 2020 FY | 489.66 Million USD | -31.48% |
| 2020 Q3 | 109.17 Million USD | -2.12% |
| 2019 Q1 | 170.31 Million USD | 3.54% |
| 2019 FY | 714.59 Million USD | 47.79% |
| 2019 Q4 | 176.37 Million USD | -7.47% |
| 2019 Q3 | 190.61 Million USD | 7.52% |
| 2019 Q2 | 177.28 Million USD | 4.09% |
| 2018 Q4 | 164.5 Million USD | 27.77% |
| 2018 FY | 483.51 Million USD | 77.01% |
| 2018 Q1 | 78.11 Million USD | 10.89% |
| 2018 Q2 | 112.14 Million USD | 43.56% |
| 2018 Q3 | 128.74 Million USD | 14.8% |
| 2017 Q2 | 70.85 Million USD | 23.27% |
| 2017 FY | 273.15 Million USD | 70.55% |
| 2017 Q4 | 70.44 Million USD | -5.28% |
| 2017 Q3 | 74.37 Million USD | 4.97% |
| 2017 Q1 | 57.48 Million USD | 1.95% |
| 2016 Q2 | 35 Million USD | 13.97% |
| 2016 Q1 | 30.71 Million USD | 7.35% |
| 2016 Q3 | 38.06 Million USD | 8.74% |
| 2016 FY | 160.16 Million USD | 69.22% |
| 2016 Q4 | 56.37 Million USD | 48.12% |
| 2015 Q1 | 16.89 Million USD | 36.7% |
| 2015 Q2 | 25.05 Million USD | 48.3% |
| 2015 Q4 | 28.61 Million USD | 18.81% |
| 2015 Q3 | 24.08 Million USD | -3.9% |
| 2015 FY | 94.65 Million USD | 179.95% |
| 2014 Q2 | 6.18 Million USD | 6.87% |
| 2014 Q3 | 9.47 Million USD | 53.04% |
| 2014 Q4 | 12.36 Million USD | 30.53% |
| 2014 FY | 33.81 Million USD | 84.97% |
| 2014 Q1 | 5.79 Million USD | 1.31% |
| 2013 FY | 18.27 Million USD | 89.79% |
| 2013 Q4 | 5.71 Million USD | 26.47% |
| 2013 Q1 | 3.38 Million USD | 0.0% |
| 2013 Q2 | 4.65 Million USD | 37.36% |
| 2013 Q3 | 4.51 Million USD | -2.92% |
| 2012 FY | 9.63 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AbCellera Biologics Inc. | 275.23 Million USD | -141.304% |
| Alkermes plc | 996.24 Million USD | 33.335% |
| Agenus Inc. | 78.18 Million USD | -749.475% |
| Aptorum Group Limited | 10.56 Thousand USD | -6285580.485% |
| Ardelyx, Inc. | 169.93 Million USD | -290.818% |
| Dyadic International, Inc. | 9.15 Million USD | -7156.277% |
| Eton Pharmaceuticals, Inc. | 22.25 Million USD | -2884.519% |
| Lantern Pharma Inc. | 17.87 Million USD | -3614.962% |
| Inhibikase Therapeutics, Inc. | 6.73 Million USD | -9765.575% |
| Novavax, Inc. | 779.12 Million USD | 14.758% |
| Janux Therapeutics, Inc. | 81.06 Million USD | -719.305% |
| Pyxis Oncology, Inc. | 82.19 Million USD | -708.002% |
| TransCode Therapeutics, Inc. | 19.41 Million USD | -3320.164% |
| Ocuphire Pharma, Inc. | 29.6 Million USD | -2143.278% |
| Outlook Therapeutics, Inc. | 53.12 Million USD | -1150.123% |
| Madrigal Pharmaceuticals, Inc. | 380.49 Million USD | -74.547% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -2632.364% |
| SELLAS Life Sciences Group, Inc. | 37.86 Million USD | -1653.796% |
| Syros Pharmaceuticals, Inc. | 30.77 Million USD | -2058.347% |
| Barinthus Biotherapeutics plc | 84.71 Million USD | -683.966% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -3704.462% |
| Xeris Biopharma Holdings, Inc. | 168.43 Million USD | -294.301% |
| Clearside Biomedical, Inc. | 32.71 Million USD | -1930.093% |
| C4 Therapeutics, Inc. | 159.78 Million USD | -315.644% |
| Alnylam Pharmaceuticals, Inc. | 1.8 Billion USD | 63.104% |
| AlloVir, Inc. | 180.93 Million USD | -267.067% |
| Arrowhead Pharmaceuticals, Inc. | 445.73 Million USD | -48.999% |
| VYNE Therapeutics Inc. | 29.68 Million USD | -2137.535% |
| Bicycle Therapeutics plc | 216.92 Million USD | -206.168% |
| BioXcel Therapeutics, Inc. | 171.9 Million USD | -286.351% |
| ChromaDex Corporation | 56.37 Million USD | -1078.001% |
| Chimerix, Inc. | 93.38 Million USD | -611.16% |
| Corbus Pharmaceuticals Holdings, Inc. | 13.9 Million USD | -4674.71% |
| Caribou Biosciences, Inc. | 150.53 Million USD | -341.187% |
| CRISPR Therapeutics AG | 463.49 Million USD | -43.291% |
| Precision BioSciences, Inc. | 92.46 Million USD | -618.282% |
| Fate Therapeutics, Inc. | 254.04 Million USD | -161.429% |
| Fortress Biotech, Inc. | 200.19 Million USD | -231.749% |
| Fortress Biotech, Inc. | 200.19 Million USD | -231.749% |
| HOOKIPA Pharma Inc. | 32.74 Million USD | -1928.171% |
| ImmuCell Corporation | 9.61 Million USD | -6805.688% |
| IDEAYA Biosciences, Inc. | 157.81 Million USD | -320.84% |
| Immix Biopharma, Inc. | 16.14 Million USD | -4014.617% |
| Incyte Corporation | 1.19 Billion USD | 44.213% |
| Innoviva, Inc. | 132.15 Million USD | -402.554% |
| IO Biotech, Inc. | 91.44 Million USD | -626.294% |
| Jaguar Health, Inc. | 42.01 Million USD | -1480.733% |
| Keros Therapeutics, Inc. | 169.27 Million USD | -292.342% |
| Ligand Pharmaceuticals Incorporated | 84.32 Million USD | -687.62% |
| ContextLogic Inc. | 387 Million USD | -71.614% |
| MiMedx Group, Inc. | 229.72 Million USD | -189.102% |
| MEI Pharma, Inc. | 34.78 Million USD | -1809.286% |
| NextCure, Inc. | 67.63 Million USD | -881.926% |
| Onconetix, Inc. | 34.9 Million USD | -1802.589% |
| Oncternal Therapeutics, Inc. | 12.74 Million USD | -5110.615% |
| Opthea Limited | 191.96 Million USD | -245.968% |
| Psyence Biomedical Ltd. | 2.75 Million USD | -24036.816% |
| Vaxcyte, Inc. | 468.04 Million USD | -41.899% |
| PDS Biotechnology Corporation | 43.04 Million USD | -1442.9% |
| Precigen, Inc. | 84.18 Million USD | -688.949% |
| Pharming Group N.V. | 225.49 Million USD | -194.533% |
| Phathom Pharmaceuticals, Inc. | 167.82 Million USD | -295.732% |
| Pieris Pharmaceuticals, Inc. | 72.56 Million USD | -815.229% |
| PureTech Health plc | 144.59 Million USD | -359.308% |
| Rigel Pharmaceuticals, Inc. | 130.26 Million USD | -409.849% |
| Avidity Biosciences, Inc. | 245.15 Million USD | -170.905% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -2632.364% |
| Sangamo Therapeutics, Inc. | 228.68 Million USD | -190.425% |
| Sol-Gel Technologies Ltd. | 30.85 Million USD | -2052.192% |
| Acelyrin, Inc. | 422.06 Million USD | -57.356% |
| Salarius Pharmaceuticals, Inc. | 12.89 Thousand USD | -5150706.577% |
| Summit Therapeutics Inc. | 87.68 Million USD | -657.413% |
| Sensei Biotherapeutics, Inc. | 37.06 Million USD | -1691.887% |
| Senti Biosciences, Inc. | 94.7 Million USD | -601.278% |
| Stoke Therapeutics, Inc. | 123.55 Million USD | -437.539% |
| Elevation Oncology, Inc. | 45.44 Million USD | -1361.426% |
| Alaunos Therapeutics, Inc. | 29.46 Million USD | -2153.707% |
| Telomir Pharmaceuticals, Inc. Common Stock | 3.94 Million USD | -16747.715% |
| Entrada Therapeutics, Inc. | 132.17 Million USD | -402.474% |
| VistaGen Therapeutics, Inc. | 34.08 Million USD | -1848.496% |
| Kintara Therapeutics, Inc. | 8.45 Million USD | -7758.774% |
| Wave Life Sciences Ltd. | 181.3 Million USD | -266.322% |
| Seer, Inc. | 110.49 Million USD | -501.091% |
| Verrica Pharmaceuticals Inc. | 70.59 Million USD | -840.795% |
| Aadi Bioscience, Inc. | 93.47 Million USD | -610.483% |
| ESSA Pharma Inc. | 32.13 Million USD | -1966.792% |
| GlycoMimetics, Inc. | 39.28 Million USD | -1590.569% |
| GT Biopharma, Inc. | 13.57 Million USD | -4792.052% |
| Inhibrx Biosciences, Inc. | 219.83 Million USD | -202.118% |
| Akebia Therapeutics, Inc. | 201.11 Million USD | -230.231% |
| Catalyst Pharmaceuticals, Inc. | 259.42 Million USD | -156.007% |
| Longboard Pharmaceuticals, Inc. | 56.75 Million USD | -1070.114% |
| Orchestra BioMed Holdings, Inc. | 54.08 Million USD | -1128.079% |
| Alzamend Neuro, Inc. | 9.93 Million USD | -6583.123% |
| Sorrento Therapeutics, Inc. | 403.56 Million USD | -64.57% |
| TRACON Pharmaceuticals, Inc. | 18.92 Million USD | -3408.611% |
| Viracta Therapeutics, Inc. | 50.69 Million USD | -1210.132% |
| Rocket Pharmaceuticals, Inc. | 259.65 Million USD | -155.776% |
| Aptose Biosciences Inc. | 52.35 Million USD | -1168.517% |
| ZyVersa Therapeutics, Inc. | 14.41 Million USD | -4508.798% |
| Soligenix, Inc. | 7.79 Million USD | -8419.867% |
| Century Therapeutics, Inc. | 56.07 Million USD | -1084.471% |
| Kura Oncology, Inc. | 165.8 Million USD | -300.56% |
| TScan Therapeutics, Inc. | 114.5 Million USD | -480.004% |
| Intensity Therapeutics, Inc. | 8.31 Million USD | -7883.472% |
| Ocean Biomedical, Inc. | 2.48 Million USD | -26662.353% |
| CytomX Therapeutics, Inc. | 107.69 Million USD | -516.673% |
| Autolus Therapeutics plc | 196.72 Million USD | -237.599% |
| Mineralys Therapeutics, Inc. | 84.65 Million USD | -684.513% |
| EyePoint Pharmaceuticals, Inc. | 116.45 Million USD | -470.312% |
| Eterna Therapeutics Inc. | 19.38 Million USD | -3326.43% |
| Adaptive Biotechnologies Corporation | 321.75 Million USD | -106.411% |
| GRI Bio, Inc. | 11.33 Million USD | -5761.827% |
| Xenetic Biosciences, Inc. | 7.05 Million USD | -9312.885% |
| Tenaya Therapeutics, Inc. | 131.19 Million USD | -406.235% |
| IGM Biosciences, Inc. | 265.59 Million USD | -150.063% |
| INmune Bio, Inc. | 29.89 Million USD | -2121.518% |
| Heron Therapeutics, Inc. | 172.55 Million USD | -284.891% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -1547.417% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -4056.268% |
| Entero Therapeutics, Inc. | 15.74 Million USD | -4119.056% |
| Milestone Pharmaceuticals Inc. | 62.09 Million USD | -969.511% |
| X4 Pharmaceuticals, Inc. | 107.52 Million USD | -517.683% |
| Atara Biotherapeutics, Inc. | 275.69 Million USD | -140.9% |
| Coherus BioSciences, Inc. | 301.45 Million USD | -120.316% |
| Verastem, Inc. | 92.08 Million USD | -621.238% |
| Abeona Therapeutics Inc. | 17.93 Million USD | -3602.241% |
| Pliant Therapeutics, Inc. | 185.72 Million USD | -257.596% |
| Tonix Pharmaceuticals Holding Corp. | 121.4 Million USD | -447.04% |
| Histogen Inc. | 14.27 Million USD | -4553.482% |
| Aprea Therapeutics, Inc. | 16.04 Million USD | -4038.454% |
| Surrozen, Inc. | 18.55 Million USD | -3480.296% |
| Organovo Holdings, Inc. | 14.91 Million USD | -4352.866% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -12947.43% |
| Ovid Therapeutics Inc. | 59.67 Million USD | -1012.971% |
| Panbela Therapeutics, Inc. | 25.64 Million USD | -2489.562% |
| CASI Pharmaceuticals, Inc. | 47 Million USD | -1312.894% |
| Cadrenal Therapeutics, Inc. Common Stock | 7.63 Million USD | -8601.148% |
| Centessa Pharmaceuticals plc | 178.13 Million USD | -272.83% |
| Hepion Pharmaceuticals, Inc. | 48.44 Million USD | -1270.842% |
| Arcturus Therapeutics Holdings Inc. | 245 Million USD | -171.075% |
| BioRestorative Therapies, Inc. | 15.36 Million USD | -4222.011% |
| Apollomics, Inc. | 54.14 Million USD | -1126.718% |
| Amarin Corporation plc | 272.35 Million USD | -143.851% |
| Mesoblast Limited | 5.9 Million USD | -11152.88% |
| Turnstone Biologics Corp. | 78.33 Million USD | -747.794% |
| Kymera Therapeutics, Inc. | 244.12 Million USD | -172.055% |
| Synaptogenix, Inc. | 8.31 Million USD | -7888.413% |
| Tiziana Life Sciences Ltd | 14.58 Million USD | -4453.305% |
| Aurinia Pharmaceuticals Inc. | 253.05 Million USD | -162.45% |
| BriaCell Therapeutics Corp. | 33.33 Million USD | -1892.63% |
| Monopar Therapeutics Inc. | 8.83 Million USD | -7420.409% |
| Exelixis, Inc. | 1.58 Billion USD | 58.145% |
| Better Therapeutics, Inc. | 38.26 Million USD | -1635.782% |
| Nurix Therapeutics, Inc. | 232.05 Million USD | -186.208% |
| Apellis Pharmaceuticals, Inc. | 855.2 Million USD | 22.341% |
| NLS Pharmaceutics AG | 11.8 Million USD | -5524.981% |
| Dermata Therapeutics, Inc. | 8.04 Million USD | -8158.552% |
| Aridis Pharmaceuticals, Inc. | 29.99 Million USD | -2114.333% |
| Gritstone bio, Inc. | 148.37 Million USD | -347.615% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -864.472% |
| TNF Pharmaceuticals, Inc. | 16.36 Million USD | -3959.512% |
| Avid Bioservices, Inc. | 25.99 Million USD | -2454.797% |
| Insmed Incorporated | 949.26 Million USD | 30.036% |
| Virpax Pharmaceuticals, Inc. | 15.68 Million USD | -4132.976% |
| MediWound Ltd. | 18.86 Million USD | -3419.954% |
| OmniAb, Inc. | 83.89 Million USD | -691.638% |
| Alector, Inc. | 248.8 Million USD | -166.937% |
| Seres Therapeutics, Inc. | 234.3 Million USD | -183.45% |
| Checkpoint Therapeutics, Inc. | 52.25 Million USD | -1171.067% |
| Zai Lab Limited | 547.47 Million USD | -21.31% |
| Revance Therapeutics, Inc. | 398.65 Million USD | -66.597% |
| Aura Biosciences, Inc. | 84.99 Million USD | -681.43% |
| Lyell Immunopharma, Inc. | 247.13 Million USD | -168.734% |
| Immunic, Inc. | 99.22 Million USD | -569.346% |
| Tarsus Pharmaceuticals, Inc. | 159.01 Million USD | -317.67% |
| Veracyte, Inc. | 357.93 Million USD | -85.55% |
| InMed Pharmaceuticals Inc. | 9.01 Billion USD | 92.633% |
| FibroGen, Inc. | 398.11 Million USD | -66.823% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -4573.786% |
| Adial Pharmaceuticals, Inc. | 6.88 Million USD | -9542.133% |
| Sonnet BioTherapeutics Holdings, Inc. | 7.12 Million USD | -9220.376% |
| Jazz Pharmaceuticals plc | 3.25 Billion USD | 79.6% |
| Cyclacel Pharmaceuticals, Inc. | 25.87 Million USD | -2466.942% |
| Amylyx Pharmaceuticals, Inc. | 316.54 Million USD | -109.812% |
| TG Therapeutics, Inc. | 198.47 Million USD | -234.624% |
| Galecto, Inc. | 35.62 Million USD | -1764.162% |
| Calithera Biosciences, Inc. | 40.68 Million USD | -1532.247% |
| Fortrea Holdings Inc. | 457.3 Million USD | -45.232% |
| KalVista Pharmaceuticals, Inc. | 54.27 Million USD | -1123.599% |
| Aptevo Therapeutics Inc. | 28.87 Million USD | -2199.83% |
| XBiotech Inc. | 37.51 Million USD | -1670.581% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -864.472% |
| Lyra Therapeutics, Inc. | 20.64 Million USD | -3116.354% |
| Foghorn Therapeutics Inc. | 142.06 Million USD | -367.507% |
| Y-mAbs Therapeutics, Inc. | 99.07 Million USD | -570.346% |
| Theravance Biopharma, Inc. | 110.71 Million USD | -499.864% |
| Ultragenyx Pharmaceutical Inc. | 958.24 Million USD | 30.692% |
| Metagenomi, Inc. Common Stock | 28.84 Million USD | -2202.461% |
| Vaxxinity, Inc. | 56.05 Million USD | -1084.894% |
| BioCryst Pharmaceuticals, Inc. | 430.64 Million USD | -54.223% |
| Gain Therapeutics, Inc. | 22.3 Million USD | -2877.119% |
| Cartesian Therapeutics, Inc. | 110.86 Million USD | -499.047% |
| NexImmune, Inc. | 28.16 Million USD | -2257.841% |
| Creative Medical Technology Holdings, Inc. | 5.53 Million USD | -11907.797% |
| Marker Therapeutics, Inc. | 17.89 Million USD | -3611.86% |
| Regeneron Pharmaceuticals, Inc. | 2.81 Billion USD | 76.409% |
| Chemomab Therapeutics Ltd. | 25.45 Million USD | -2508.685% |
| Scopus BioPharma Inc. | 11.71 Million USD | -5569.244% |
| RAPT Therapeutics, Inc. | 127.06 Million USD | -422.694% |
| Ainos, Inc. | 12.95 Million USD | -5027.478% |
| Pluri Inc. | 22.48 Million USD | -2854.382% |
| Prothena Corporation plc | 282.4 Million USD | -135.174% |
| Adaptimmune Therapeutics plc | 200.02 Million USD | -232.036% |
| Celularity Inc. | 215.05 Million USD | -208.821% |
| Rallybio Corporation | 78.93 Million USD | -741.414% |
| Cue Biopharma, Inc. | 19.54 Million USD | -3298.552% |
| MeiraGTx Holdings plc | 151.07 Million USD | -339.604% |
| Omeros Corporation | 94.75 Million USD | -600.937% |
| Humacyte, Inc. | 23.49 Million USD | -2726.51% |
| Immunocore Holdings plc | 308.04 Million USD | -115.603% |
| Cocrystal Pharma, Inc. | 3.39 Million USD | -19491.298% |
| Cidara Therapeutics, Inc. | 86.86 Million USD | -664.571% |
| Blueprint Medicines Corporation | 722.86 Million USD | 8.123% |
| CalciMedica, Inc. | 21.81 Million USD | -2944.163% |
| Cabaletta Bio, Inc. | 74.66 Million USD | -789.559% |
| Marinus Pharmaceuticals, Inc. | 160.54 Million USD | -313.694% |
| Scholar Rock Holding Corporation | 171.29 Million USD | -287.72% |
| Sana Biotechnology, Inc. | 294.94 Million USD | -125.18% |
| Pulmatrix, Inc. | 22.03 Million USD | -2913.636% |
| Elicio Therapeutics, Inc. | 34.57 Million USD | -1820.882% |
| Vigil Neuroscience, Inc. | 88.86 Million USD | -647.356% |
| Intellia Therapeutics, Inc. | 551.56 Million USD | -20.411% |
| Adlai Nortye Ltd. American Depositary Shares | 72.55 Million USD | -815.418% |
| Cytokinetics, Incorporated | 173.61 Million USD | -282.546% |
| Eloxx Pharmaceuticals, Inc. | 34.41 Million USD | -1829.588% |
| Nutriband Inc. | 5.73 Million USD | -11482.515% |
| Protara Therapeutics, Inc. | 43.61 Million USD | -1422.814% |
| Vor Biopharma Inc. | 126.03 Million USD | -426.949% |
| Roivant Sciences Ltd. | 1.18 Billion USD | 44.151% |
| Evogene Ltd. | 27.79 Million USD | -2289.87% |
| ProKidney Corp. | 151.52 Million USD | -338.316% |
| Applied Therapeutics, Inc. | 74.17 Million USD | -795.376% |
| Hoth Therapeutics, Inc. | 7.69 Million USD | -8533.959% |
| BridgeBio Pharma, Inc. | 614.22 Million USD | -8.127% |
| CorMedix Inc. | 48.95 Million USD | -1256.567% |
| BioLineRx Ltd. | 50.8 Million USD | -1207.321% |
| Tango Therapeutics, Inc. | 150.7 Million USD | -340.707% |
| Galectin Therapeutics Inc. | 38.07 Million USD | -1644.445% |
| Atai Life Sciences N.V. | 125.78 Million USD | -428.0% |
| Renovaro Biosciences Inc. | 81.63 Million USD | -713.511% |
| Aerovate Therapeutics, Inc. | 81.4 Million USD | -715.813% |
| Zentalis Pharmaceuticals, Inc. | 252.55 Million USD | -162.974% |
| Sagimet Biosciences Inc. | 32.74 Million USD | -1928.543% |
| MediciNova, Inc. | 10.9 Million USD | -5992.925% |
| Praxis Precision Medicines, Inc. | 128.82 Million USD | -415.56% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -9048.603% |
| GeoVax Labs, Inc. | 6.02 Million USD | -10928.328% |
| Axsome Therapeutics, Inc. | 476.36 Million USD | -39.421% |
| Biomea Fusion, Inc. | 126.13 Million USD | -426.535% |
| PTC Therapeutics, Inc. | 1.31 Billion USD | 49.373% |
| Mereo BioPharma Group plc | 35.84 Million USD | -1752.98% |
| Cullinan Oncology, Inc. | 191.08 Million USD | -247.558% |
| Syndax Pharmaceuticals, Inc. | 229.95 Million USD | -188.816% |
| Absci Corporation | 73.66 Million USD | -801.562% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -2307.893% |
| 4D Molecular Therapeutics, Inc. | 133.59 Million USD | -397.152% |
| Dyne Therapeutics, Inc. | 242.16 Million USD | -174.256% |
| Kiniksa Pharmaceuticals, Ltd. | 262.04 Million USD | -153.444% |
| Ventyx Biosciences, Inc. | 207.99 Million USD | -219.31% |
| Allakos Inc. | 196.05 Million USD | -238.753% |
| Imunon, Inc. | 20.31 Million USD | -3169.971% |
| Fulcrum Therapeutics, Inc. | 113.46 Million USD | -485.31% |
| Corcept Therapeutics Incorporated | 368.61 Million USD | -80.175% |
| BioAtla, Inc. | 129.68 Million USD | -412.114% |
| NLS Pharmaceutics AG | 11.8 Million USD | -5524.981% |
| Bio-Path Holdings, Inc. | 15.84 Million USD | -4092.041% |
| Allogene Therapeutics, Inc. | 84.91 Million USD | -682.102% |
| Larimar Therapeutics, Inc. | 41.75 Million USD | -1490.462% |
| XOMA Corporation | 46.46 Million USD | -1329.406% |
| Kezar Life Sciences, Inc. | 111.17 Million USD | -497.408% |
| Cara Therapeutics, Inc. | 142.46 Million USD | -366.188% |
| aTyr Pharma, Inc. | 12.97 Million USD | -5017.074% |
| Aligos Therapeutics, Inc. | 103.65 Million USD | -540.72% |
| Akero Therapeutics, Inc. | 172.87 Million USD | -284.188% |
| Viridian Therapeutics, Inc. | 254.76 Million USD | -160.69% |
| Eliem Therapeutics, Inc. | 37.4 Million USD | -1675.409% |
| EyeGate Pharmaceuticals, Inc. | 8.22 Million USD | -7974.894% |
| Akari Therapeutics, Plc | 16.8 Million USD | -3851.833% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -29106.41% |
| Halozyme Therapeutics, Inc. | 299.31 Million USD | -121.886% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -9770.288% |
| UroGen Pharma Ltd. | 138.88 Million USD | -378.187% |
| Sutro Biopharma, Inc. | 243 Million USD | -173.301% |
| ZIVO Bioscience, Inc. | 7.27 Million USD | -9029.615% |
| Orgenesis Inc. | 45.75 Million USD | -1351.461% |
| Entera Bio Ltd. | 8.86 Million USD | -7395.993% |
| GH Research PLC | 41.22 Million USD | -1511.142% |
| Lisata Therapeutics, Inc. | 25.7 Million USD | -2483.418% |
| Reneo Pharmaceuticals, Inc. | 83.05 Million USD | -699.664% |
| Xencor, Inc. | 306.97 Million USD | -116.35% |
| 60 Degrees Pharmaceuticals, Inc. | 4.93 Million USD | -13361.655% |
| Replimune Group, Inc. | 234.77 Million USD | -182.888% |
| Coeptis Therapeutics Holdings, Inc. | 20.48 Million USD | -3141.331% |
| Vanda Pharmaceuticals Inc. | 191.79 Million USD | -246.277% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -9770.288% |
| Portage Biotech Inc. | 18.19 Million USD | -3549.349% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -9048.603% |
| Olema Pharmaceuticals, Inc. | 104.96 Million USD | -532.754% |
| OncoCyte Corporation | 25.63 Million USD | -2490.572% |
| Qualigen Therapeutics, Inc. | 6.09 Million USD | -10795.469% |
| Processa Pharmaceuticals, Inc. | 11.45 Million USD | -5696.818% |
| Purple Biotech Ltd. | -22.46 Million USD | 3056.091% |
| CollPlant Biotechnologies Ltd. | 16.48 Million USD | -3930.006% |
| scPharmaceuticals Inc. | 65.17 Million USD | -918.971% |
| ProMIS Neurosciences, Inc. | 8.45 Million USD | -7757.16% |
| HilleVax, Inc. | 133.34 Million USD | -398.065% |
| NeuroSense Therapeutics Ltd. | 10.28 Million USD | -6357.414% |
| Tharimmune, Inc. | 9.45 Million USD | -6924.109% |
| Genprex, Inc. | 31.06 Million USD | -2038.226% |
| Neumora Therapeutics, Inc. Common Stock | 187.52 Million USD | -254.162% |
| Atossa Therapeutics, Inc. | 31.37 Million USD | -2016.662% |
| XTL Biopharmaceuticals Ltd. | 765 Thousand USD | -86716.34% |
| Virios Therapeutics, Inc. | 5.44 Million USD | -12093.04% |
| OKYO Pharma Limited | 8243.57 USD | -8056421.628% |
| Savara Inc. | 15.74 Million USD | -4118.133% |
| Curis, Inc. | 58.35 Million USD | -1038.112% |
| Daré Bioscience, Inc. | 33.6 Million USD | -1876.069% |
| Carmell Therapeutics Corporation | 5.09 Million USD | -12941.661% |
| Titan Pharmaceuticals, Inc. | 7.46 Million USD | -8801.555% |
| Achieve Life Sciences, Inc. | 27.02 Million USD | -2357.794% |
| BeiGene, Ltd. | 3.28 Billion USD | 79.792% |
| Kiromic BioPharma, Inc. | 19.93 Million USD | -3230.834% |
| Revolution Medicines, Inc. Warrant | 498.76 Million USD | -33.158% |
| Protagonist Therapeutics, Inc. | 153.65 Million USD | -332.24% |
| Erasca, Inc. | 141.52 Million USD | -369.278% |
| bluebird bio, Inc. | 240.23 Million USD | -176.46% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -14570.838% |
| BioMarin Pharmaceutical Inc. | 1.74 Billion USD | 61.968% |
| DBV Technologies S.A. | 92.16 Million USD | -620.643% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -14570.838% |
| Moderna, Inc. | 6.39 Billion USD | 89.613% |
| Vincerx Pharma, Inc. | 42.6 Million USD | -1458.697% |
| Fresh Tracks Therapeutics, Inc. | 14.36 Million USD | -4523.034% |
| Molecular Templates, Inc. | 63.09 Million USD | -952.678% |
| Acrivon Therapeutics, Inc. Common Stock | 66.7 Million USD | -895.705% |
| Travere Therapeutics, Inc. | 472 Million USD | -40.708% |
| Monte Rosa Therapeutics, Inc. | 143.31 Million USD | -363.429% |
| Spruce Biosciences, Inc. | 62.08 Million USD | -969.787% |
| Celldex Therapeutics, Inc. | 43.41 Million USD | -1429.795% |
| Cogent Biosciences, Inc. | 208.13 Million USD | -219.101% |
| MacroGenics, Inc. | 217.21 Million USD | -205.755% |
| RenovoRx, Inc. | 11.39 Million USD | -5727.878% |
| Adicet Bio, Inc. | 152.03 Million USD | -336.828% |
| Prime Medicine, Inc. | 186.63 Million USD | -255.845% |
| Aditxt, Inc. | 25.95 Million USD | -2459.25% |
| Adagene Inc. | 41.83 Million USD | -1487.673% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -8985.309% |
| Quantum-Si incorporated | 111.65 Million USD | -494.798% |
| Maravai LifeSciences Holdings, Inc. | 171.85 Million USD | -286.468% |
| Acurx Pharmaceuticals, Inc. | 14.57 Million USD | -4455.876% |
| Voyager Therapeutics, Inc. | 35.82 Million USD | -1754.014% |
| SciSparc Ltd. | 9.01 Million USD | -7270.381% |
| Vericel Corporation | 142.04 Million USD | -367.576% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -7572.066% |
| Minerva Neurosciences, Inc. | 23.08 Million USD | -2776.507% |
| Generation Bio Co. | 144.46 Million USD | -359.721% |
| Astria Therapeutics, Inc. | 83.03 Million USD | -699.886% |
| Black Diamond Therapeutics, Inc. | 86.46 Million USD | -668.153% |
| Arcutis Biotherapeutics, Inc. | 295.72 Million USD | -124.586% |
| Invivyd, Inc. | 205.75 Million USD | -222.784% |
| Relay Therapeutics, Inc. | 72.15 Million USD | -820.391% |
| Quoin Pharmaceuticals, Ltd. | 9.37 Million USD | -6981.567% |
| Spero Therapeutics, Inc. | 75.25 Million USD | -782.538% |
| Artelo Biosciences, Inc. | 10.28 Million USD | -6356.158% |
| 2seventy bio, Inc. | 289.88 Million USD | -129.105% |
| ADMA Biologics, Inc. | 66.58 Million USD | -897.424% |
| Clene Inc. | 41.07 Million USD | -1516.987% |
| Capricor Therapeutics, Inc. | 12.8 Million USD | -5085.438% |
| Boundless Bio, Inc. Common Stock | 54.79 Million USD | -1112.032% |
| GeoVax Labs, Inc. | 6.02 Million USD | -10928.328% |
| Recursion Pharmaceuticals, Inc. | 352.04 Million USD | -88.652% |
| Citius Pharmaceuticals, Inc. | 36.73 Million USD | -1708.082% |
| Contineum Therapeutics, Inc. Class A Common Stock | 33.72 Million USD | -1869.121% |
| Relmada Therapeutics, Inc. | 103.7 Million USD | -540.436% |
| Finch Therapeutics Group, Inc. | 32.58 Million USD | -1937.942% |
| ALX Oncology Holdings Inc. | 170.27 Million USD | -290.036% |
| Vir Biotechnology, Inc. | 767.72 Million USD | 13.491% |
| Evaxion Biotech A/S | 22.27 Million USD | -2882.241% |
| Ocular Therapeutix, Inc. | 135.54 Million USD | -389.985% |
| Verve Therapeutics, Inc. | 234.88 Million USD | -182.757% |
| Trevena, Inc. | 38.41 Million USD | -1628.959% |
| Surrozen, Inc. | 18.55 Million USD | -3480.296% |
| Tyra Biosciences, Inc. | 79.94 Million USD | -730.752% |
| Cingulate Inc. | 22.75 Million USD | -2818.14% |
| Galmed Pharmaceuticals Ltd. | -7.49 Million USD | 8964.722% |
| Unity Biotechnology, Inc. | 44.66 Million USD | -1386.881% |
| Tenax Therapeutics, Inc. | 8.23 Million USD | -7965.943% |
| Terns Pharmaceuticals, Inc. | 102.55 Million USD | -547.58% |
| ACADIA Pharmaceuticals Inc. | 754.08 Million USD | 11.927% |
| Connect Biopharma Holdings Limited | 62.07 Million USD | -969.925% |
| Clearmind Medicine Inc. | 8.74 Million USD | -7497.739% |
| Kronos Bio, Inc. | 128.11 Million USD | -418.385% |
| Bolt Biotherapeutics, Inc. | 84.07 Million USD | -689.972% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -22543.996% |
| Viking Therapeutics, Inc. | 100.82 Million USD | -558.698% |
| Statera Biopharma, Inc. | 28.82 Million USD | -2203.699% |
| ImmunityBio, Inc. | 362.87 Million USD | -83.025% |
| Korro Bio, Inc. | 84.53 Million USD | -685.654% |
| Kineta, Inc. | 21.15 Million USD | -3039.275% |
| BioVie Inc. | 31.95 Million USD | -1978.688% |
| Codexis, Inc. | 66.51 Million USD | -898.444% |
| Celularity Inc. | 215.05 Million USD | -208.821% |
| Crinetics Pharmaceuticals, Inc. | 226.62 Million USD | -193.064% |
| Celcuity Inc. | 66.23 Million USD | -902.781% |
| Virax Biolabs Group Limited | 6.54 Million USD | -10044.167% |
| Cibus, Inc. | 320.3 Million USD | -107.348% |
| Eledon Pharmaceuticals, Inc. | 43 Million USD | -1444.523% |
| eFFECTOR Therapeutics, Inc. | 33.84 Million USD | -1862.371% |
| IN8bio, Inc. | 30.33 Million USD | -2089.224% |
| Kodiak Sciences Inc. | 277.32 Million USD | -139.486% |
| Annexon, Inc. | 143.72 Million USD | -362.101% |
| Adverum Biotechnologies, Inc. | 127.59 Million USD | -420.527% |
| Assembly Biosciences, Inc. | 22.9 Million USD | -2799.057% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -103672.656% |
| Ionis Pharmaceuticals, Inc. | 779.58 Million USD | 14.808% |
| Eyenovia, Inc. | 25.4 Million USD | -2514.081% |
| Puma Biotechnology, Inc. | 140.31 Million USD | -373.324% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -11840.759% |
| Xilio Therapeutics, Inc. | 79.13 Million USD | -739.277% |
| Arcellx, Inc. | 200.19 Million USD | -231.742% |
| Cardiff Oncology, Inc. | 45.9 Million USD | -1346.939% |
| Enanta Pharmaceuticals, Inc. | 216.41 Million USD | -206.891% |
| Regulus Therapeutics Inc. | 9.95 Million USD | -6570.132% |
| Moolec Science SA | 52.75 Million USD | -1159.028% |
| Acumen Pharmaceuticals, Inc. | 61.13 Million USD | -986.305% |
| Geron Corporation | 70.44 Million USD | -842.839% |
| LAVA Therapeutics N.V. | 46.54 Million USD | -1327.041% |
| Royalty Pharma plc | 862.4 Million USD | 22.989% |
| Atea Pharmaceuticals, Inc. | 94.07 Million USD | -605.996% |
| Greenwich LifeSciences, Inc. | 9.32 Million USD | -7020.01% |
| TFF Pharmaceuticals, Inc. | 22.62 Million USD | -2834.989% |
| Mersana Therapeutics, Inc. | 207.81 Million USD | -219.589% |
| Humacyte, Inc. | 23.49 Million USD | -2726.51% |
| Structure Therapeutics Inc. | 102.77 Million USD | -546.213% |
| 89bio, Inc. | 151.2 Million USD | -339.238% |
| PMV Pharmaceuticals, Inc. | 80.13 Million USD | -728.814% |
| Avenue Therapeutics, Inc. | 14.54 Million USD | -4467.71% |
| Genelux Corporation | 24.33 Million USD | -2629.176% |
| Trevi Therapeutics, Inc. | 33.92 Million USD | -1857.801% |
| Lexicon Pharmaceuticals, Inc. | 172.86 Million USD | -284.19% |
| Notable Labs, Ltd. | 14.77 Million USD | -4396.581% |
| Liquidia Corporation | 87.98 Million USD | -654.847% |
| Mustang Bio, Inc. | 48.5 Million USD | -1269.343% |
| Immunovant, Inc. | 282.7 Million USD | -134.922% |
| Quantum-Si incorporated | 111.65 Million USD | -494.798% |
| Arbutus Biopharma Corporation | 22.54 Million USD | -2845.994% |
| DiaMedica Therapeutics Inc. | 21.26 Million USD | -3022.89% |
| Vera Therapeutics, Inc. | 102.01 Million USD | -551.046% |
| Acasti Pharma Inc. | 11.3 Million USD | -5776.869% |
| MiNK Therapeutics, Inc. | 22.92 Million USD | -2797.526% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -4056.268% |
| Xenon Pharmaceuticals Inc. | 46.54 Million USD | -1326.98% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -58436.639% |
| NeuroBo Pharmaceuticals, Inc. | 15.88 Million USD | -4080.694% |
| Tempest Therapeutics, Inc. | 29.15 Million USD | -2177.824% |
| Soleno Therapeutics, Inc. | 41.38 Million USD | -1504.835% |
| PepGen Inc. | 84.76 Million USD | -683.504% |
| Moleculin Biotech, Inc. | 29.63 Million USD | -2141.386% |
| United Therapeutics Corporation | 885.1 Million USD | 24.964% |
| Nuvectis Pharma, Inc. | 22.89 Million USD | -2800.576% |
| Solid Biosciences Inc. | 104.31 Million USD | -536.673% |
| BriaCell Therapeutics Corp. | 32.72 Million USD | -1929.44% |
| Immuneering Corporation | 58.41 Million USD | -1036.984% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -12947.43% |
| Silo Pharma, Inc. | 3.92 Million USD | -16834.457% |
| Belite Bio, Inc | 31.66 Million USD | -1997.212% |
| XOMA Corporation | 46.46 Million USD | -1329.406% |
| ARS Pharmaceuticals, Inc. | 67.55 Million USD | -883.19% |
| Bionomics Limited | 17.89 Billion USD | 96.288% |
| Apogee Therapeutics, Inc. | 93 Million USD | -614.111% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 1961.393% |
| uniQure N.V. | 285.08 Million USD | -132.963% |
| Cassava Sciences, Inc. | 105.95 Million USD | -526.806% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -8985.309% |
| Poseida Therapeutics, Inc. | 194.2 Million USD | -241.978% |
| Forte Biosciences, Inc. | 32.47 Million USD | -1944.97% |
| Anebulo Pharmaceuticals, Inc. | 8.3 Million USD | -7893.315% |
| Enlivex Therapeutics Ltd. | 29.39 Million USD | -2159.381% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -11840.759% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -4573.786% |
| FibroBiologics, Inc. Common Stock | 8.88 Million USD | -7371.538% |
| Altimmune, Inc. | 30.55 Million USD | -2073.534% |
| Amicus Therapeutics, Inc. | 427.65 Million USD | -55.301% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 1961.393% |
| Compugen Ltd. | 43.97 Million USD | -1410.416% |
| Peak Bio, Inc. | 1249.13 USD | -53168505.349% |
| Zevra Therapeutics, Inc. | 74.12 Million USD | -796.04% |
| Benitec Biopharma Inc. | 22.38 Million USD | -2867.317% |
| Spyre Therapeutics, Inc. | 243.18 Million USD | -173.098% |
| NKGen Biotech, Inc. Common Stock | 28.54 Million USD | -2226.823% |
| Zura Bio Limited | 62.63 Million USD | -960.291% |
| PolyPid Ltd. | 21.04 Million USD | -3055.833% |
| Aileron Therapeutics, Inc. | 16.27 Million USD | -3980.517% |
| NKGen Biotech, Inc. Warrants | 28.54 Million USD | -2226.823% |
| Instil Bio, Inc. | 85.78 Million USD | -674.197% |
| argenx SE | 1.53 Billion USD | 56.692% |
| Immunome, Inc. | 122.82 Million USD | -440.747% |
| Compass Therapeutics, Inc. | 48.47 Million USD | -1270.134% |
| Verona Pharma plc | 67.15 Million USD | -889.028% |
| enGene Holdings Inc. Warrants | 25.88 Million USD | -2465.752% |
| Shattuck Labs, Inc. | 93.61 Million USD | -609.451% |
| CervoMed Inc. | 14.95 Million USD | -4340.135% |
| LENZ Therapeutics, Inc. | 70.7 Million USD | -839.345% |
| Plus Therapeutics, Inc. | 8.54 Million USD | -7673.233% |
| Dianthus Therapeutics, Inc. | 51 Million USD | -1202.245% |
| Moolec Science SA | 52.75 Million USD | -1159.028% |
| Enveric Biosciences, Inc. | 16.44 Million USD | -3937.739% |
| Inovio Pharmaceuticals, Inc. | 132.55 Million USD | -401.033% |
| AnaptysBio, Inc. | 181.56 Million USD | -265.783% |
| Design Therapeutics, Inc. | 78.19 Million USD | -749.399% |
| Leap Therapeutics, Inc. | 87.04 Million USD | -663.025% |
| NeurAxis, Inc. | 8.82 Million USD | -7428.965% |
| Seelos Therapeutics, Inc. | 12.58 Million USD | -5177.275% |
| Lumos Pharma, Inc. | 38.66 Million USD | -1617.69% |
| Achilles Therapeutics plc | 75.25 Million USD | -782.526% |
| enGene Holdings Inc. Common Stock | 25.88 Million USD | -2465.752% |
| 180 Life Sciences Corp. | 13.47 Million USD | -4827.806% |
| Opiant Pharmaceuticals, Inc. | 26.5 Million USD | -2405.977% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -22543.996% |
| Nutriband Inc. | 5.73 Million USD | -11482.515% |
| ORIC Pharmaceuticals, Inc. | 110.78 Million USD | -499.517% |
| CG Oncology, Inc. Common stock | 55.65 Million USD | -1093.368% |
| Fractyl Health, Inc. Common Stock | 50.87 Million USD | -1205.342% |
| Rani Therapeutics Holdings, Inc. | 66.09 Million USD | -904.773% |
| MoonLake Immunotherapeutics | 54.12 Million USD | -1127.101% |
| Palisade Bio, Inc. | 13.32 Million USD | -4886.074% |
| Tourmaline Bio, Inc. | 45.4 Million USD | -1362.585% |
| Beam Therapeutics Inc. | 554.19 Million USD | -19.84% |
| Neurogene Inc. | 55.58 Million USD | -1094.871% |
| Mirum Pharmaceuticals, Inc. | 248.48 Million USD | -167.273% |
| AEON Biopharma, Inc. | 48.42 Million USD | -1271.379% |
| CARGO Therapeutics, Inc. Common Stock | 96.71 Million USD | -586.739% |
| Sesen Bio, Inc. | 78.38 Million USD | -747.329% |
| Enliven Therapeutics, Inc. | 83.52 Million USD | -695.107% |
| Kiora Pharmaceuticals, Inc. | 12.58 Million USD | -5176.48% |
| Iovance Biotherapeutics, Inc. | 450.99 Million USD | -47.263% |
| Taysha Gene Therapies, Inc. | 87.89 Million USD | -655.655% |
| Athira Pharma, Inc. | 125.46 Million USD | -429.343% |
| Vaccinex, Inc. | 23.45 Million USD | -2731.571% |
| HCW Biologics Inc. | 21.02 Million USD | -3058.456% |
| XOMA Corporation | 46.46 Million USD | -1329.406% |
| Nektar Therapeutics | 190.9 Million USD | -247.897% |
| Arvinas, Inc. | 480 Million USD | -38.364% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -29106.41% |
| Merus N.V. | 200.49 Million USD | -231.254% |
| Omega Therapeutics, Inc. | 103.35 Million USD | -542.586% |
| Quince Therapeutics, Inc. | 34.62 Million USD | -1818.385% |
| Rezolute, Inc. | 70.38 Million USD | -843.562% |
| Clene Inc. | 41.07 Million USD | -1516.987% |
| Indaptus Therapeutics, Inc. | 16.37 Million USD | -3954.987% |
| BeyondSpring Inc. | 24.86 Million USD | -2571.003% |
| Synlogic, Inc. | 58.53 Million USD | -1034.67% |
| Allarity Therapeutics, Inc. | 17.89 Million USD | -3611.966% |
| Phio Pharmaceuticals Corp. | 4.49 Million USD | -14685.062% |
| Peak Bio, Inc. | 1249.13 USD | -53168505.349% |
| Werewolf Therapeutics, Inc. | 60.44 Million USD | -998.741% |
| Krystal Biotech, Inc. | 160.42 Million USD | -313.988% |
| Karyopharm Therapeutics Inc. | 270.63 Million USD | -145.406% |
| SpringWorks Therapeutics, Inc. | 348.03 Million USD | -90.825% |
| Lipella Pharmaceuticals Inc. | 2.15 Million USD | -30694.015% |
| MannKind Corporation | 125.59 Million USD | -428.79% |
| Ikena Oncology, Inc. | 84.57 Million USD | -685.255% |
| Cyclerion Therapeutics, Inc. | 9.64 Million USD | -6784.472% |
| Gyre Therapeutics, Inc. | 89.6 Million USD | -641.225% |
| Gossamer Bio, Inc. | 183.75 Million USD | -261.422% |
| CohBar, Inc. | 12.38 Million USD | -5261.068% |
| Cognition Therapeutics, Inc. | 50.72 Million USD | -1209.331% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -2307.893% |
| Legend Biotech Corporation | 583.14 Million USD | -13.89% |
| Mural Oncology plc | 192.07 Million USD | -245.781% |
| Biora Therapeutics, Inc. | 67.14 Million USD | -889.091% |
| PaxMedica, Inc. Common Stock | 16.14 Million USD | -4013.557% |
| Disc Medicine, Inc. | 91.12 Million USD | -628.829% |
| Champions Oncology, Inc. | 28.11 Million USD | -2262.665% |
| REGENXBIO Inc. | 321.15 Million USD | -106.798% |
| Ensysce Biosciences, Inc. | 5.36 Million USD | -12287.913% |
| Anavex Life Sciences Corp. | 55.75 Million USD | -1091.163% |
| Cellectar Biosciences, Inc. | 38.96 Million USD | -1604.656% |
| Edgewise Therapeutics, Inc. | 114.35 Million USD | -480.765% |
| Vaxart, Inc. | 90.72 Million USD | -632.034% |
| PharmaCyte Biotech, Inc. | 8.52 Million USD | -7695.122% |
| Aldeyra Therapeutics, Inc. | 42.79 Million USD | -1451.955% |
| Cellectis S.A. | 97.32 Million USD | -582.434% |
| Longeveron Inc. | 21.25 Million USD | -3025.388% |
| Repare Therapeutics Inc. | 167.35 Million USD | -296.843% |
| Sarepta Therapeutics, Inc. | 1.36 Billion USD | 51.195% |
| Inozyme Pharma, Inc. | 75.64 Million USD | -777.976% |
| Revolution Medicines, Inc. | 498.76 Million USD | -33.158% |
| Nymox Pharmaceutical Corporation | 6.65 Million USD | -9884.14% |
| Third Harmonic Bio, Inc. | 43.95 Million USD | -1411.0% |
| ArriVent BioPharma, Inc. Common Stock | 74.59 Million USD | -790.394% |
| AN2 Therapeutics, Inc. | 69.63 Million USD | -853.752% |
| Anixa Biosciences, Inc. | 11.06 Million USD | -5904.928% |
| Vertex Pharmaceuticals Incorporated | 4.77 Billion USD | 86.091% |
| Denali Therapeutics Inc. | 527.23 Million USD | -25.969% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -7572.066% |
| Veru Inc. | 101.34 Million USD | -555.31% |
| Corvus Pharmaceuticals, Inc. | 23.4 Million USD | -2737.378% |
| Cingulate Inc. | 22.75 Million USD | -2818.14% |
| Passage Bio, Inc. | 108.38 Million USD | -512.742% |
| Context Therapeutics Inc. | 25.07 Million USD | -2548.886% |
| Exicure, Inc. | 14.07 Million USD | -4618.279% |
| Day One Biopharmaceuticals, Inc. | 206.06 Million USD | -222.3% |
| Oramed Pharmaceuticals Inc. | 43.3 Million USD | -1433.787% |
| Scinai Immunotherapeutics Ltd. | 9.17 Million USD | -7136.831% |
| Rhythm Pharmaceuticals, Inc. | 252.48 Million USD | -163.045% |
| Nuvalent, Inc. | 149.49 Million USD | -344.268% |
| ABVC BioPharma, Inc. | 8.06 Million USD | -8132.962% |
| Carisma Therapeutics, Inc. | 103.65 Million USD | -540.757% |
| Unicycive Therapeutics, Inc. | 21.44 Million USD | -2996.391% |
| OmniAb, Inc. | 83.89 Million USD | -691.638% |
| Anew Medical, Inc. | 1.3 Million USD | -50955.048% |
| Fennec Pharmaceuticals Inc. | 32.76 Million USD | -1927.057% |
| Lipocine Inc. | 15.08 Million USD | -4304.104% |
| Lexeo Therapeutics, Inc. Common Stock | 68.51 Million USD | -869.371% |
| Nautilus Biotechnology, Inc. | 76.15 Million USD | -772.131% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -1547.417% |
| G1 Therapeutics, Inc. | 114.84 Million USD | -478.307% |
| Bellerophon Therapeutics, Inc. | 22.38 Million USD | -2867.052% |
| Ocugen, Inc. | 71.56 Million USD | -828.005% |
| Mind Medicine (MindMed) Inc. | 93.86 Million USD | -607.546% |
| Q32 Bio Inc. | 92.68 Million USD | -616.6% |
| Brainstorm Cell Therapeutics Inc. | 21.17 Million USD | -3036.606% |
| Alumis Inc. Common Stock | 158.17 Million USD | -319.883% |
| Equillium, Inc. | 50.6 Million USD | -1212.384% |
| Kyverna Therapeutics, Inc. | 62.4 Million USD | -964.233% |
| Coya Therapeutics, Inc. | 13.9 Million USD | -4676.113% |
| CNS Pharmaceuticals, Inc. | 18.86 Million USD | -3420.494% |
| Galera Therapeutics, Inc. | 46.95 Million USD | -1314.549% |
| Evelo Biosciences, Inc. | 108.46 Million USD | -512.307% |
| Comera Life Sciences Holdings, Inc. | 12.39 Million USD | -5259.151% |
| Dominari Holdings Inc. | 23.83 Million USD | -2686.428% |
| Edesa Biotech, Inc. | 9.22 Million USD | -7101.154% |
| vTv Therapeutics Inc. | 11.9 Million USD | -5477.769% |
| Bio-Techne Corporation | 563.03 Million USD | -17.957% |
| Agios Pharmaceuticals, Inc. | 408.8 Million USD | -62.46% |
| Harmony Biosciences Holdings, Inc. | 268.75 Million USD | -147.118% |
| Prelude Therapeutics Incorporated | 132.27 Million USD | -402.087% |
| Candel Therapeutics, Inc. | 14.41 Million USD | -4508.598% |
| iTeos Therapeutics, Inc. | 163.69 Million USD | -305.719% |
| Nkarta, Inc. | 131.65 Million USD | -404.478% |
| BioCardia, Inc. | 12.12 Million USD | -5379.292% |
| Iterum Therapeutics plc | 47.46 Million USD | -1299.143% |